Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-30 14:59:01 - browse：72888

UnitedHealth Group and Optum are getting rid of the name of their tech-driven care management company just months after the company faced congressional criticism over the use of its algorithms to cut off payments for patients’ care.

Discontinuing the NaviHealth name is part of a broader rebranding of Optum’s division that provides services to people at home and in post-acute facilities. The move also encapsulates how UnitedHealth is pushing to control every piece of patient care outside of the hospital and distancing itself from the aspects that have generated controversy.

Starting in the first quarter of 2024, Optum’s post-acute-care companies will be called Home & Community Care, according to internal documents obtained by STAT. However, Optum advised employees that “Home & Community Care should not be directly next to the Optum logo” in marketing materials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Telehealth for opioid use disorder is lifesaving

focus

WSS

Telehealth for opioid use disorder is lifesaving

UnitedHealth’s board chair also owns a personal investment firm

PEPFAR is under serious threat — and so is global health

HHS leader on health, climate change and biopharma emissions

New weight loss drugs vying to be the next Wegovy or Mounjaro

Lawmakers consider Medicare pay reforms for doctors

explore

Wikipedia

focus

Activists slam private health insurers over coverage restrictions

STAT Summit: Michael J. Fox on progress in Parkinson's research

Apple is now the first public company to be valued at $3 trillion

FDA panel endorses Alnylam’s heart drug — after picking it apart

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

STAT Readout Newsletter: Today's biggest biotech updates

Drug repurposing or repositioning? The language matters

Acelyrin, a rare IPO success, stumbles in its first big test

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How to make the FDA’s new prescription one

explore

White House touts steps to stem shortages of cancer treatments

FDA approves updated Covid vaccines

CEOs share strategies for surviving biotech slump

FDA struggles to regulate food additives, sometimes for decades

A common UTI test for kids haunts adults as a traumatic 'nightmare'

WATCH: Why do bright lights make us see spots?

focus

focus

hotspot

entertainment